Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Language
Publication year range
1.
Arq. bras. med. vet. zootec. (Online) ; 73(1): 99-107, Jan.-Feb. 2021. tab
Article in English | LILACS, VETINDEX | ID: biblio-1153067

ABSTRACT

This study evaluated the most common toxic agents affecting domestic cats, the clinical signs of toxicity, and the therapeutic approaches for recovery. A survey on poisoning in cats was conducted among small animal veterinary practitioners from 2017 to 2018. Of the 748 completed questionnaires, 543 (72.6%) were evaluated. Pesticides and household cleaning supplies were the most common causes of poisoning in cats. The toxicant groups included pesticides and household cleaning supplies (organophosphates), human drugs (acetaminophen), plants/plant derivatives (lily), and veterinary drugs (tramadol). The major clinical signs for these four groups of toxicants were (1) acetaminophen poisoning, which caused oxidative erythrocyte damage; (2) muscarinic and nicotinic cholinergic syndrome, which resulted from organophosphate poisoning; (3) acute kidney injury, which resulted from intoxication of lily; and (4) serotonin syndrome, which resulted from tramadol toxicosis. Interventions for treating poisoning in cats were based on the clinical presentation of animals. In the present study, the significant toxins identified to be dangerous for cats were characterized using the obtained data in Brazil as well as the main associated clinical signs and therapy recommended by veterinarians.(AU)


Objetiva-se com este trabalho caracterizar os principais toxicantes para gatos domésticos, bem como os prevalentes sinais clínicos e a terapêutica associada. Uma pesquisa sobre envenenamento em gatos foi realizada entre médicos veterinários no período de 2017 a 2018. Dos 748 questionários preenchidos, 543 (72,6%) foram avaliados. Pesticidas e domissanitários foram os principais causadores de intoxicação em gatos. Entre os grupos tóxicos, destacaram-se, na categoria pesticidas e domissanitários (organofosforados), medicamentos humanos (acetaminofeno), plantas e derivados de planta (lírio) e medicamentos veterinários (tramadol). Os principais sinais clínicos para os quatro grupos de substâncias tóxicas foram: (1) intoxicação por acetaminofeno, que causou dano eritrocitário oxidativo; (2) síndrome colinérgica muscarínica e nicotínica, resultante do envenenamento por organofosforado; (3) lesão renal aguda, causada pela intoxicação por lírio; e (4) síndrome serotoninérgica, resultante da exposição ao tramadol. As intervenções realizadas para o tratamento dos envenenamentos foram justificáveis mediante a apresentação clínica dos animais. Por meio dos dados obtidos, puderam-se caracterizar os principais tóxicos para gatos no Brasil, bem como os principais sinais clínicos associados e a terapêutica preconizada pelos médicos veterinários.(AU)


Subject(s)
Animals , Cats , Organophosphorus Compounds/toxicity , Poisoning/etiology , Poisoning/veterinary , Tramadol/toxicity , Lilium/toxicity , Acetaminophen/toxicity , Serotonin Agents/toxicity , Oxidative Stress , Muscarinic Antagonists/toxicity , Acute Kidney Injury/chemically induced
2.
Neurosci Lett ; 664: 34-37, 2018 01 18.
Article in English | MEDLINE | ID: mdl-29126775

ABSTRACT

We examined whether lithium carbonate (Li2CO3, 100mg/L) is able to prevent memory impairment induced by scopolamine. Moreover, we evaluated the effects of lithium on anxiety-like behavior and acetylcholinesterase activity in adult zebrafish. We demonstrated that lithium prevents the memory impairment induced by scopolamine, decreases exploration and increases the activity of acetylcholinesterase in zebrafish. Collectively, this contributes to a better understanding of the pharmacology of lithium, its interaction with cholinergic neurotransmission, and its possible application to therapeutic treatments aimed at improving cognition.


Subject(s)
Lithium Carbonate/therapeutic use , Maze Learning/drug effects , Memory Disorders/chemically induced , Memory Disorders/prevention & control , Scopolamine/toxicity , Animals , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Cholinesterase Inhibitors/pharmacology , Cholinesterase Inhibitors/therapeutic use , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Female , Lithium Carbonate/pharmacology , Male , Maze Learning/physiology , Memory Disorders/psychology , Motor Activity/drug effects , Motor Activity/physiology , Muscarinic Antagonists/toxicity , Zebrafish
3.
Peptides ; 31(9): 1756-60, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20600432

ABSTRACT

Systemic (IP) and/or intraseptal (IS) administration of scopolamine (SCP) and diazepam (DZP) induce amnesia, whereas IP injection of the neuropeptide substance P (SP) and choline chloride (ChCl) produce memory facilitation. The septohippocampal cholinergic system has been pointed out as a possible site of SCP and DZP-induced amnesia as well as for the mnemonic effects induced by SP and ChCl. We performed a series of experiments in order to investigate the interactions between cholinergic and GABA/benzodiazepine (GABA/BZD) systems with the SPergic system on inhibitory avoidance retention. Male Wistar rats were trained and tested in a step-down inhibitory avoidance task (1.0 mA footshock). Animals received, pre-training, IP (1.0 mg/kg) or IS (1.0 nM/0.5 microl) injection of DZP, SCP (SCP; 1.0 mg/kg - IP or 0.5 microM/0.5 microl--IS) or vehicle (VEH). Immediately after training they received an IP or IS injections of SP 1-11 (50 microg/kg--IP or 1.0 nM/0.5 microl--IS), SP 1-7 (167 microg/kg--IP or 1.0 nM/0.5 microl--IS), ChCl (20 mg/kg--IP or 0.3 microM/0.5 microl--IS) or VEH. Rats pretreated with SCP and DZP showed amnesia. Post-trial treatments with SP 1-11, SP 1-7 or ChCl blocked the amnesic effects of SCP and DZP. These findings suggest an interaction between SPergic and cholinergic mechanisms with GABAergic systems in the modulation of inhibitory avoidance retention and that the effects of these treatments are mediated, at least in part, by interactions in the septohippocampal pathway.


Subject(s)
Amnesia/prevention & control , Choline/therapeutic use , Diazepam/toxicity , Protective Agents/therapeutic use , Scopolamine/toxicity , Substance P/therapeutic use , Amnesia/chemically induced , Animals , Avoidance Learning , GABA Modulators/toxicity , Male , Muscarinic Antagonists/toxicity , Neurons/drug effects , Peptide Fragments/therapeutic use , Rats , Rats, Wistar , Retention, Psychology/drug effects
4.
Behav Pharmacol ; 21(5-6): 556-62, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20520530

ABSTRACT

This study was conducted to evaluate the effects of exposure to diphenyl diselenide (PhSe)2 on cognitive impairment induced by scopolamine, a muscarinic antagonist, using the Y-maze and Morris water maze tests in mice. One hour before the tests, mice were treated with (PhSe)2 (50 mg/kg, oral) and 30 min later memory impairment was induced by administration of scopolamine (1 mg/kg, intraperitoneal). (PhSe)2 (50 mg/kg, oral) significantly improved scopolamine-induced memory impairment in the Y-maze test. At the probe trial session in Morris water maze, (PhSe)2 (50 mg/kg, oral) significantly decreased the escape latency, increased the number of crossings in the platform local, and increased the time spent in the platform quadrant when compared with the scopolamine-treated group. General locomotor activity was similar in all groups. This study showed that (PhSe)2 ameliorated the impairments of spatial long-term memory and short-term memory, showed by the performance of mice in the Morris water maze and Y-maze tasks, respectively. These results suggest that (PhSe)2 may be useful for the treatment of cognitive impairment that may hold significant therapeutic value in alleviating certain memory deficits observed in Alzheimer's disease.


Subject(s)
Alzheimer Disease/drug therapy , Benzene Derivatives/pharmacology , Memory Disorders/drug therapy , Organoselenium Compounds/pharmacology , Alzheimer Disease/physiopathology , Animals , Disease Models, Animal , Male , Maze Learning/drug effects , Mice , Motor Activity/drug effects , Muscarinic Antagonists/toxicity , Scopolamine/toxicity , Time Factors
5.
J Neurosci Res ; 87(3): 691-700, 2009 Feb 15.
Article in English | MEDLINE | ID: mdl-18816796

ABSTRACT

All five subtypes of muscarinic acetylcholine receptors (mAChR; M(1)-M(5)) are expressed in the hippocampus, where they are involved both in cognitive functions and in synaptic plasticity, such as long-term potentiation (LTP). Muscarinic toxins (MTs) are small proteins from mamba snake venoms that display exquisite discrimination between mAChRs. MT1 acts as an agonist at M(1) and an antagonist at M(4) receptors, with similar affinities for both. MT3, the most selective antagonist available for M(4) receptors, infused into the CA1 region immediately after training caused amnesia in the rat, indicating the participation of M(4) receptors in memory consolidation. Our goal was to investigate the participation of M(4) receptor in neurotransmission at the hippocampal Schaffer collaterals-CA1 synapses. Two different preparations were used: 1) field potential recordings in freshly prepared rat hippocampal slices with high-frequency stimulation to induce potentiation and 2) whole-cell voltage clamp in cultured hippocampal organotypic slices with paired stimuli. In preparation 1, a dose of MT3 that was previously shown to cause amnesia blocked LTP; the nonselective antagonist scopolamine blocked LTP without affecting basal transmission, although it was depressed with higher concentration. In preparation 2, basal transmission was decreased and LTP induction was prevented by an MT3 concentration that would bind mainly to M(4) receptors. Although M(1) receptors appeared to modulate transmission positively at these excitatory synapses, M(1) activation concomitant with M(4) blockade (by MT1) only allowed a brief, short-term potentiation. Accordingly, M(4) blockade by MT3 strongly supports a permissive role of M(4) receptors and suggests their necessary participation in synaptic plasticity at these synapses.


Subject(s)
Hippocampus/physiology , Neurons/physiology , Receptor, Muscarinic M4/physiology , Synapses/physiology , Synaptic Transmission , Animals , Excitatory Postsynaptic Potentials/drug effects , Hippocampus/cytology , Hippocampus/drug effects , In Vitro Techniques , Intercellular Signaling Peptides and Proteins , Long-Term Potentiation/drug effects , Male , Muscarinic Antagonists/toxicity , Neurons/drug effects , Neurotoxins/toxicity , Patch-Clamp Techniques , Peptides/toxicity , Rats , Rats, Wistar , Receptor, Muscarinic M4/antagonists & inhibitors , Scopolamine/toxicity , Synapses/drug effects
6.
Article in English | MEDLINE | ID: mdl-16624469

ABSTRACT

This study verifies the effects of bovine brain phosphatidylserine (PS) on passive avoidance (PA) and contextual fear conditioning (CFC) tests in scopolamine-treated mice. Mice received daily i.p. 50 mg/kg PS or 0.2 M Tris pH 7.4 (TRIS) for 5 days. On day 6, mice received saline (TRIS-SAL and PS-SAL) or 1 mg/kg SCO (TRIS-SCO and PS-SCO) i.p. After 20 min, the animals were submitted to PA (experiment 1) or CFC (experiment 2) training sessions, and tests were performed 24 h later. Latency in entering the dark chamber of the PA apparatus presented by TRIS-SCO (but not PS-SCO) group in the test was significantly higher than those presented by controls. Except for TRIS-SCO, all the groups presented higher latencies in the test compared to the training session. In experiment 2, the TRIS-SCO (but not PS-SCO) group presented significantly lower freezing duration than that presented by the TRIS-SAL group in the test. Animals treated with PS alone presented higher freezing duration than that presented by the TRIS-SAL group. The results demonstrate that PS attenuates SCO-induced amnesia in both PA and CFC tests. In addition, PS per se improves retention in the CFC test.


Subject(s)
Amnesia/prevention & control , Brain Chemistry/physiology , Muscarinic Antagonists/toxicity , Phosphatidylserines/pharmacology , Scopolamine/antagonists & inhibitors , Scopolamine/toxicity , Amnesia/chemically induced , Animals , Association Learning/drug effects , Avoidance Learning/drug effects , Cattle , Conditioning, Psychological/drug effects , Emotions/drug effects , Fear/physiology , Male , Memory/drug effects , Mice
7.
Bioorg Med Chem ; 13(13): 4184-90, 2005 Jul 01.
Article in English | MEDLINE | ID: mdl-15878668

ABSTRACT

Five new piperidine alkaloids were designed from natural (-)-3-O-acetyl-spectaline and (-)-spectaline that were obtained from the flowers of Senna spectabilis (sin. Cassia spectabilis, Leguminosae). Two semi-synthetic analogues (7 and 9) inhibited rat brain acetylcholinesterase, showing IC50 of 7.32 and 15.1 microM, and were 21 and 9.5 times less potent against rat brain butyrylcholinesterase, respectively. Compound 9 (1mg/kg, i.p.) was fully efficacious in reverting scopolamine-induced amnesia in mice. The two active compounds (7 and 9) did not show overt toxic effects at the doses tested in vivo.


Subject(s)
Acetylcholinesterase/chemistry , Alkaloids , Cholinesterase Inhibitors/chemical synthesis , Cholinesterase Inhibitors/pharmacology , Drug Design , Piperidines , Plants, Medicinal/chemistry , Alkaloids/chemical synthesis , Alkaloids/chemistry , Alkaloids/pharmacology , Amnesia/chemically induced , Amnesia/drug therapy , Animals , Brain/drug effects , Brain/enzymology , Butyrylcholinesterase/chemistry , Cholinesterase Inhibitors/chemistry , Flowers/chemistry , Male , Mice , Molecular Structure , Muscarinic Antagonists/toxicity , Piperidines/chemical synthesis , Piperidines/chemistry , Piperidines/pharmacology , Plant Extracts/pharmacology , Rats , Rats, Wistar , Scopolamine/toxicity , Structure-Activity Relationship
8.
Epilepsy Behav ; 6(3): 328-36, 2005 May.
Article in English | MEDLINE | ID: mdl-15820339

ABSTRACT

Wet dog shakes (WDS) and head shakes (HS) are associated with experimentally induced convulsive seizures. We sought to determine whether these behaviors are correlated or not with major (status epilepticus (SE) or fully kindled animals) or minor (non-SE or partially kindled animals) seizure severity. WDS are directly correlated with SE induced by intracerebral star fruit extract (Averrhoa carambola) injection and with kindled animals in the amygdala fast kindling model. On the other hand, WDS are inversely correlated with SE induced by intracerebral bicuculline and pilocarpine injections. Systemic pilocarpine in animals pretreated with methyl-scopolamine barely induced WDS or HS. The role of shaking behaviors may vary from ictal to anticonvulsant depending on the experimental seizure model, circuitries involved, and stimulus intensity. The physical presence of acrylic helmets may per se inhibit the HS response. Also, methyl-scopolamine, a drug incapable of crossing the blood-brain barrier, can induce HS in animals without acrylic helmets.


Subject(s)
Behavior, Animal/physiology , Disease Models, Animal , Kindling, Neurologic/physiology , Seizures/physiopathology , Amygdala/radiation effects , Analysis of Variance , Animals , Behavior, Animal/drug effects , Behavior, Animal/radiation effects , Bicuculline/toxicity , Electric Stimulation/methods , Electroencephalography/methods , Functional Laterality/physiology , GABA Antagonists/toxicity , Hippocampus/drug effects , Hippocampus/physiopathology , Kindling, Neurologic/drug effects , Kindling, Neurologic/radiation effects , Male , Microscopy, Interference/methods , Muscarinic Agonists/toxicity , Muscarinic Antagonists/toxicity , Pilocarpine/toxicity , Rats , Rats, Wistar , Scopolamine/toxicity , Seizures/chemically induced , Stereotaxic Techniques , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL